uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 25, 2002

FDA Advises Consumers of Risk of Severe Liver Toxicity with Kava

On March 25, 2002 the U.S. Food and Drug Administration (FDA)issued a Consumer Advisory, as well as a letter to health care providers, advising of the potential risk of severe liver injury associated with the use of kava-containing dietary supplements. (See posting of January 7, 2002 for an earlier communication from the FDA on this subject).

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at